SG11201500632VA - Anti-viral methods and the use of an anti-viral agent - Google Patents
Anti-viral methods and the use of an anti-viral agentInfo
- Publication number
- SG11201500632VA SG11201500632VA SG11201500632VA SG11201500632VA SG11201500632VA SG 11201500632V A SG11201500632V A SG 11201500632VA SG 11201500632V A SG11201500632V A SG 11201500632VA SG 11201500632V A SG11201500632V A SG 11201500632VA SG 11201500632V A SG11201500632V A SG 11201500632VA
- Authority
- SG
- Singapore
- Prior art keywords
- viral
- methods
- agent
- viral agent
- viral methods
- Prior art date
Links
- 230000000840 anti-viral effect Effects 0.000 title 1
- 239000003443 antiviral agent Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
- C07K14/42—Lectins, e.g. concanavalin, phytohaemagglutinin
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Botany (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261682932P | 2012-08-14 | 2012-08-14 | |
PCT/SG2013/000329 WO2014027958A1 (en) | 2012-08-14 | 2013-08-05 | Anti-viral methods and the use of an anti-viral agent |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201500632VA true SG11201500632VA (en) | 2015-02-27 |
Family
ID=50101349
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10201701154RA SG10201701154RA (en) | 2012-08-14 | 2013-08-05 | Anti-viral methods and the use of an anti-viral agent |
SG11201500632VA SG11201500632VA (en) | 2012-08-14 | 2013-08-05 | Anti-viral methods and the use of an anti-viral agent |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10201701154RA SG10201701154RA (en) | 2012-08-14 | 2013-08-05 | Anti-viral methods and the use of an anti-viral agent |
Country Status (4)
Country | Link |
---|---|
KR (1) | KR102257437B1 (en) |
BR (1) | BR112015003353A2 (en) |
SG (2) | SG10201701154RA (en) |
WO (1) | WO2014027958A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102007096B1 (en) * | 2017-12-18 | 2019-08-02 | 경희대학교 산학협력단 | Composition for preventing or treating hearing loss comprising Viscum ovalifolium extracts |
US20220339241A1 (en) | 2019-07-09 | 2022-10-27 | Unichem Laboratories Ltd | Stable formulations of recombinant proteins |
CN113350482B (en) * | 2021-05-31 | 2022-05-27 | 中国食品药品检定研究院 | Application of phytohemagglutinin PHA-E in preparation of medicine for treating diseases caused by coronavirus |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5565200A (en) * | 1995-04-14 | 1996-10-15 | University Of Southern California | Pharmaceutical preparations derived from korean mistletoe |
KR101012507B1 (en) * | 2008-01-08 | 2011-02-08 | (주)디딤바이오텍 | A composition for sanitary supplies comprising mucosal immunoadjuvant and a preparation method thereof |
DE102011003478A1 (en) * | 2011-02-01 | 2012-08-02 | Cytavis Biopharma Gmbh | Antiviral agent containing recombinant mistletoe lectins |
-
2013
- 2013-08-05 SG SG10201701154RA patent/SG10201701154RA/en unknown
- 2013-08-05 SG SG11201500632VA patent/SG11201500632VA/en unknown
- 2013-08-05 KR KR1020157006685A patent/KR102257437B1/en active IP Right Grant
- 2013-08-05 WO PCT/SG2013/000329 patent/WO2014027958A1/en active Application Filing
- 2013-08-05 BR BR112015003353A patent/BR112015003353A2/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR102257437B1 (en) | 2021-05-31 |
KR20150042852A (en) | 2015-04-21 |
BR112015003353A2 (en) | 2017-12-05 |
WO2014027958A1 (en) | 2014-02-20 |
SG10201701154RA (en) | 2017-04-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1208439A1 (en) | 5-azaindazole compounds and methods of use 5- | |
IL235536A0 (en) | Metamaterial devices and methods of using the same | |
HK1203493A1 (en) | Substituted azabicycles and use thereof | |
EP2912178A4 (en) | Super-enhancers and methods of use thereof | |
EP2828258A4 (en) | Novelpyridopyrimidine derivatives and use thereof | |
ZA201500698B (en) | Hydroxamate substituted azaindoline-cyanine dyes and bioconjugates of the same | |
EP2834421A4 (en) | Stabilizing agents and methods of use thereof | |
HUE042637T2 (en) | Laminates and methods of making the same | |
HK1221416A1 (en) | Formulations of oxabicycloheptanes and oxabicycloheptenes | |
IL240248A0 (en) | Met-binding agents and uses thereof | |
GB201301626D0 (en) | Composition comprising 15-OHEPA and methods of using the same | |
IL234756A0 (en) | Immunomodulatory agent and uses therefor | |
GB201216649D0 (en) | Agents and methods | |
EP2852397A4 (en) | Huwentoxin-iv variants and methods of use | |
HK1203198A1 (en) | Substituted phenylimidazopyrazoles and use thereof | |
HK1198833A1 (en) | N-acylpeptide derivatives and their uses n- | |
HK1210809A1 (en) | Beta-hexosyl-transferases and uses thereof | |
EP2909285A4 (en) | Gelling agents and methods of using the same | |
EP2906576A4 (en) | Glycosphingolipids and methods of use thereof | |
SG10201701154RA (en) | Anti-viral methods and the use of an anti-viral agent | |
HK1202853A1 (en) | Thixotropic agents and methods of use | |
ZA201408128B (en) | Etract of greyia radlkoferi and use thereof | |
GB201305297D0 (en) | Novel agents and uses thereof | |
EP2834635A4 (en) | Heparin-bulking agent compositions and methods thereof | |
HK1207154A1 (en) | C1q-adiponectin complex and use thereof c1q- |